DD Breimer

840 total citations
21 papers, 689 citations indexed

About

DD Breimer is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, DD Breimer has authored 21 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 9 papers in Clinical Biochemistry and 9 papers in Pharmacology. Recurrent topics in DD Breimer's work include Metabolism and Genetic Disorders (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). DD Breimer is often cited by papers focused on Metabolism and Genetic Disorders (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). DD Breimer collaborates with scholars based in Netherlands, United Kingdom and Austria. DD Breimer's co-authors include Meindert Danhof, R. Jochemsen, J. K. Boeijinga, A. R. Janssens, P. Spoelstra, J. Hermans, Angela G. E. M. de Boer, AF Cohen, P. Whiteman and John Posner and has published in prestigious journals such as British Journal of Clinical Pharmacology and Pharmacology.

In The Last Decade

DD Breimer

20 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DD Breimer Netherlands 15 270 147 129 123 89 21 689
Michael S. Ching Australia 18 295 1.1× 195 1.3× 56 0.4× 170 1.4× 134 1.5× 48 893
Alvin N. Kotake United States 16 259 1.0× 67 0.5× 62 0.5× 98 0.8× 84 0.9× 27 663
E. E. Ohnhaus Switzerland 20 412 1.5× 173 1.2× 41 0.3× 229 1.9× 113 1.3× 62 1.1k
C von Bahr Sweden 11 244 0.9× 100 0.7× 35 0.3× 122 1.0× 67 0.8× 22 555
P Bechtel France 15 495 1.8× 110 0.7× 32 0.2× 201 1.6× 198 2.2× 55 935
P. Arvela Finland 17 276 1.0× 197 1.3× 42 0.3× 184 1.5× 65 0.7× 49 826
C B McAllister United States 12 682 2.5× 208 1.4× 92 0.7× 321 2.6× 135 1.5× 15 1.2k
D. Kadar Canada 15 293 1.1× 125 0.9× 79 0.6× 129 1.0× 148 1.7× 29 729
MJ Brodie United Kingdom 16 387 1.4× 390 2.7× 90 0.7× 225 1.8× 82 0.9× 33 920
Karl Ludwig Rost Germany 15 483 1.8× 152 1.0× 26 0.2× 245 2.0× 193 2.2× 23 870

Countries citing papers authored by DD Breimer

Since Specialization
Citations

This map shows the geographic impact of DD Breimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DD Breimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DD Breimer more than expected).

Fields of papers citing papers by DD Breimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DD Breimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DD Breimer. The network helps show where DD Breimer may publish in the future.

Co-authorship network of co-authors of DD Breimer

This figure shows the co-authorship network connecting the top 25 collaborators of DD Breimer. A scholar is included among the top collaborators of DD Breimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DD Breimer. DD Breimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breimer, DD, et al.. (1991). Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.. British Journal of Clinical Pharmacology. 32(1). 11–16. 44 indexed citations
2.
Boer, Angela G. E. M. de, et al.. (1991). Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.. British Journal of Clinical Pharmacology. 32(6). 697–704. 28 indexed citations
3.
4.
Breimer, DD, et al.. (1989). Stereoselectivity in the urinary excretion of the mercapturates of (R‐) and (S‐) alpha‐bromoisovalerylurea in man.. British Journal of Clinical Pharmacology. 28(2). 151–154. 13 indexed citations
5.
Brummelen, P. van, et al.. (1989). Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.. British Journal of Clinical Pharmacology. 27(2). 179–189. 13 indexed citations
6.
Danhof, Meindert, et al.. (1988). Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a ‘cocktail’ approach.. British Journal of Clinical Pharmacology. 26(4). 373–384. 47 indexed citations
7.
Posner, John, et al.. (1987). The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.. British Journal of Clinical Pharmacology. 24(1). 51–55. 35 indexed citations
8.
Bruining, G.J., et al.. (1985). Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.. British Journal of Clinical Pharmacology. 20(6). 703–706.
9.
Breimer, DD, et al.. (1985). Central effects during the continuous osmotic infusion of a benzodiazepine (triazolam).. British Journal of Clinical Pharmacology. 19(6). 807–815. 8 indexed citations
10.
Bakker, Willem H., et al.. (1984). Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.. British Journal of Clinical Pharmacology. 18(5). 701–706. 20 indexed citations
11.
Spoelstra, P., et al.. (1984). Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.. British Journal of Clinical Pharmacology. 18(5). 707–715. 45 indexed citations
12.
Jochemsen, R., et al.. (1983). Pharmacokinetics of brotizolam in the elderly.. British Journal of Clinical Pharmacology. 16(S2). 299S–307S. 21 indexed citations
13.
Jochemsen, R., et al.. (1983). Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.. British Journal of Clinical Pharmacology. 16(S2). 291S–297S. 26 indexed citations
14.
Jochemsen, R., et al.. (1983). Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.. British Journal of Clinical Pharmacology. 15(3). 295–302. 32 indexed citations
15.
Jochemsen, R., et al.. (1983). Pharmacokinetics of oral brotizolam in patients with liver cirrhosis.. British Journal of Clinical Pharmacology. 16(S2). 315S–322S. 10 indexed citations
16.
Jochemsen, R., et al.. (1983). Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.. British Journal of Clinical Pharmacology. 16(S2). 285S–290S. 25 indexed citations
17.
Danhof, Meindert, et al.. (1982). Differential effects of enzyme induction on antipyrine metabolite formation.. British Journal of Clinical Pharmacology. 13(3). 379–386. 71 indexed citations
18.
Buchanan, N., Michael D. Davis, Meindert Danhof, & DD Breimer. (1980). Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.. British Journal of Clinical Pharmacology. 10(4). 363–368. 16 indexed citations
19.
20.
Vermeulen, Nico, et al.. (1979). Pharmacokinetics of pemoline in plasma, saliva and urine following oral administration.. British Journal of Clinical Pharmacology. 8(5). 459–463. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael S. Ching Breakdown of academic impact, for papers by Alvin N. Kotake Breakdown of academic impact, for papers by E. E. Ohnhaus Breakdown of academic impact, for papers by C von Bahr Breakdown of academic impact, for papers by P Bechtel Breakdown of academic impact, for papers by P. Arvela Breakdown of academic impact, for papers by C B McAllister Breakdown of academic impact, for papers by D. Kadar Breakdown of academic impact, for papers by MJ Brodie Breakdown of academic impact, for papers by Karl Ludwig Rost
Rankless by CCL
2026